These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34328268)

  • 1. Response to "SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients".
    Malinis M; Cohen E; Azar MM
    Am J Transplant; 2021 Dec; 21(12):4106-4107. PubMed ID: 34328268
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients.
    Mossad SB
    Am J Transplant; 2021 Dec; 21(12):4105. PubMed ID: 34212494
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients.
    Marinaki S; Adamopoulos S; Degiannis D; Roussos S; Pavlopoulou ID; Hatzakis A; Boletis IN
    Am J Transplant; 2021 Aug; 21(8):2913-2915. PubMed ID: 33864722
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients.
    Malinis M; Cohen E; Azar MM
    Am J Transplant; 2021 Aug; 21(8):2916-2918. PubMed ID: 34101990
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients.
    Del Bello A; Abravanel F; Marion O; Couat C; Esposito L; Lavayssière L; Izopet J; Kamar N
    Am J Transplant; 2022 Jan; 22(1):322-323. PubMed ID: 34331842
    [No Abstract]   [Full Text] [Related]  

  • 6. Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients.
    Bestard O; Jouve T; Castells L; Lopez M; Muñoz M; Crespo E; Toapanta N; Esperalba J; Campos-Varela I; Pont T; Len O; Campins M; Moreso F
    Am J Transplant; 2022 Feb; 22(2):673-675. PubMed ID: 34554648
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on COVID-19 vaccination in pediatric solid organ transplant recipients.
    Dulek DE; Ardura MI; Green M; Michaels MG; Chaudhuri A; Vasquez L; Danziger-Isakov L; Posfay-Barbe KM; McCulloch MI; L'Huillier AG; Benden C
    Pediatr Transplant; 2022 Aug; 26(5):e14235. PubMed ID: 35060251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.
    Giannella M; Pierrotti LC; Helanterä I; Manuel O
    Transpl Int; 2021 Oct; 34(10):1776-1788. PubMed ID: 34450686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients.
    Holden IK; Bistrup C; Nilsson AC; Hansen JF; Abazi R; Davidsen JR; Poulsen MK; Lindvig SO; Justesen US; Johansen IS
    J Intern Med; 2021 Dec; 290(6):1264-1267. PubMed ID: 34237179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination.
    Wadei HM; Gonwa TA; Leoni JC; Shah SZ; Aslam N; Speicher LL
    Am J Transplant; 2021 Oct; 21(10):3496-3499. PubMed ID: 33890410
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review.
    Galmiche S; Luong Nguyen LB; Tartour E; de Lamballerie X; Wittkop L; Loubet P; Launay O
    Clin Microbiol Infect; 2022 Feb; 28(2):163-177. PubMed ID: 35020589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric solid organ transplant recipients demonstrate robust cell-mediated and humoral responses to three doses of mRNA SARS-CoV-2 vaccine.
    Bratic JS; Gans HA; Chen SF; Banaei N; Johnston EM; Sear K; Samreth S; Nadimpalli SS
    Am J Transplant; 2022 Dec; 22(12):3047-3052. PubMed ID: 36083190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
    Boyarsky BJ; Barbur I; Chiang TP; Ou MT; Greenberg RS; Teles AT; Krach MR; López JI; Garonzik-Wang JM; Avery RK; Massie AB; Segev DL; Werbel WA
    Transplantation; 2021 Nov; 105(11):e270-e271. PubMed ID: 34284420
    [No Abstract]   [Full Text] [Related]  

  • 14. Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls.
    Yanis A; Haddadin Z; Spieker AJ; Waqfi D; Rankin DA; Talj R; Thomas L; Birdwell KA; Ezzell L; Blair M; Eason J; Varjabedian R; Warren CM; Nochowicz CH; Olson EC; Simmons JD; Yoder S; Guy M; Thomsen I; Chappell JD; Kalams SA; Halasa NB
    Transpl Infect Dis; 2022 Feb; 24(1):e13772. PubMed ID: 34905653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness of additional primary SARS-CoV-2 vaccine doses for solid organ transplant recipients.
    Radcliffe C; Azar MM; Cohen E; Tucker M; Grubaugh ND; Malinis M
    Clin Transplant; 2022 Mar; 36(3):e14601. PubMed ID: 35064939
    [No Abstract]   [Full Text] [Related]  

  • 16. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients.
    Stock PG; Henrich TJ; Segev DL; Werbel WA
    J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34143755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients.
    Boyarsky BJ; Chiang TP; Ou MT; Werbel WA; Massie AB; Segev DL; Garonzik-Wang JM
    Transplantation; 2021 Aug; 105(8):e82-e83. PubMed ID: 34098566
    [No Abstract]   [Full Text] [Related]  

  • 18. Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients.
    Huang HJ; Yi SG; Mobley CM; Saharia A; Bhimaraj A; Moore LW; Kloc M; Adrogue HE; Graviss EA; Nguyen DT; Eagar TN; Jones SL; Ankoma-Sey V; MacGillivray TE; Knight RJ; Gaber AO; Ghobrial RM
    Clin Transplant; 2022 May; 36(5):e14600. PubMed ID: 35083796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective study.
    Ajlan AA; Ali T; Aleid H; Almeshari K; DeVol E; Alkaff MA; Fajji L; Alali A; Halabi D; Althuwaidi S; Alghamdi S; Ullah A; Alrajhi A; Bzeizi K; Almaghrabi R; Marquez KAH; Elmikkaoui B; Albogumi E; Aldakhil H; Al-Awwami M; Broering DC
    BMC Infect Dis; 2022 Oct; 22(1):786. PubMed ID: 36229772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update.
    Mitchell J; Alejo JL; Chiang TPY; Kim J; Chang A; Abedon AT; Avery RK; Tobian AAR; Massie AB; Levan ML; Warren DS; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 Jul; 106(7):e338-e340. PubMed ID: 35426888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.